These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2313288

  • 21. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
    Fuller RW, Hemrick-Luecke SK, Robertson DW.
    Biochem Pharmacol; 1988 Sep 01; 37(17):3343-7. PubMed ID: 3135812
    [Abstract] [Full Text] [Related]

  • 22. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
    Giovanni A, Sieber BA, Heikkila RE, Sonsalla PK.
    J Pharmacol Exp Ther; 1994 Sep 01; 270(3):1000-7. PubMed ID: 7932147
    [Abstract] [Full Text] [Related]

  • 23. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G, Nwanze E, Luthman J, Sundström E.
    Acta Physiol Scand; 1986 Oct 01; 128(2):187-94. PubMed ID: 3535380
    [Abstract] [Full Text] [Related]

  • 24. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
    Giovanni A, Sieber BA, Heikkila RE, Sonsalla PK.
    J Pharmacol Exp Ther; 1991 May 01; 257(2):691-7. PubMed ID: 2033514
    [Abstract] [Full Text] [Related]

  • 25. 7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced ATP loss in the mouse striatum.
    Royland JE, Delfani K, Langston JW, Janson AM, Di Monte DA.
    Brain Res; 1999 Aug 21; 839(1):41-8. PubMed ID: 10482797
    [Abstract] [Full Text] [Related]

  • 26. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 27. A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Denton T, Howard BD.
    J Neurochem; 1987 Aug 08; 49(2):622-30. PubMed ID: 3496426
    [Abstract] [Full Text] [Related]

  • 28. Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria.
    Ramsay RR, Singer TP.
    J Biol Chem; 1986 Jun 15; 261(17):7585-7. PubMed ID: 3486869
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine inhibits proton motive force in energized liver mitochondria.
    Singh Y, Bhatnagar R, Sidhu GS, Batra JK, Krishna G.
    Arch Biochem Biophys; 1989 May 15; 271(1):217-22. PubMed ID: 2540715
    [Abstract] [Full Text] [Related]

  • 31. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
    Vyas I, Heikkila RE, Nicklas WJ.
    J Neurochem; 1986 May 15; 46(5):1501-7. PubMed ID: 3485701
    [Abstract] [Full Text] [Related]

  • 32. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW, Hemrick-Luecke SK, Perry KW.
    J Pharmacol Exp Ther; 1988 Nov 15; 247(2):531-5. PubMed ID: 3141609
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Uptake of 1-methyl-4-phenylpyridinium ion (MPP+) and ATP content in synaptosomes.
    Matsunaga M, Shirane Y, Aiuchi T, Nakamura Y, Nakaya K.
    Biol Pharm Bull; 1996 Jan 15; 19(1):29-33. PubMed ID: 8820906
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Spontaneous recovery of MPTP-damaged catecholamine systems in goldfish brain areas.
    Poli A, Gandolfi O, Lucchi R, Barnabei O.
    Brain Res; 1992 Jul 10; 585(1-2):128-34. PubMed ID: 1511296
    [Abstract] [Full Text] [Related]

  • 37. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) serves as methyl donor for dopamine: a possible mechanism of action.
    Charlton CG.
    J Geriatr Psychiatry Neurol; 1992 Jul 10; 5(2):114-8. PubMed ID: 1590912
    [Abstract] [Full Text] [Related]

  • 38. 1-Methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine (MCTP): an alicyclic MPTP-like neurotoxin.
    Youngster SK, Saari WS, Heikkila RE.
    Neurosci Lett; 1987 Aug 18; 79(1-2):151-6. PubMed ID: 3499585
    [Abstract] [Full Text] [Related]

  • 39. 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
    Johnson EA, Wu EY, Rollema H, Booth RG, Trevor AJ, Castagnoli N.
    Eur J Pharmacol; 1989 Jul 04; 166(1):65-74. PubMed ID: 2806366
    [Abstract] [Full Text] [Related]

  • 40. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain.
    Mizuno Y, Sone N, Saitoh T.
    J Neurochem; 1987 Jun 04; 48(6):1787-93. PubMed ID: 3106573
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.